Association of Gut Microbiota‐Derived Short‐Chain Fatty Acids With Persistent Elevated Serum Transaminase Levels in Normal Weight and Obesity: A Pilot Study

Although obesity is the most common risk factor for hepatic steatosis, this disease may occur in normal-weight individuals. While gut microbial metabolites such as short-chain fatty acids (SCFAs) have been associated with obesity and metabolic disease, the relationship among fecal SCFA concentrations, SCFA-producing bacteria, and hepatic steatosis with and without obesity is not fully understood. This pilot study aimed to compare fecal SCFA concentrations and SCFA-producing gut bacteria in four study groups: 7 individuals with normal-weight and normal alanine aminotransferase levels (Nw-N ALT), 7 individuals with normal-weight and elevated ALT levels (Nw-E ALT), 12 individuals with obesity and normal ALT levels and (Ob-N ALT), and 18 individuals with obesity and elevated ALT levels (Ob-E ALT). Fecal SCFA concentrations were quantified using gas chromatography, and gut microbiota was characterized by sequencing 16S rRNA. Median fecal SCFA concentrations (propionate, butyrate, and valerate) were highest in the Ob-E ALT group and lowest in the Nw-N ALT group (<i>p</i> < 0.05). These SCFA concentrations were also higher in obese than in normal-weight individuals regardless of ALT levels (<i>p</i> < 0.05) and in elevated ALT individuals regardless of obesity status, although the difference lost significance after correction for multiple testing. Notably, the abundance of <i>Roseburia</i> was higher in Ob-N ALT and Ob-E ALT than in the Nw-N ALT group and correlated positively with fecal SCFA concentrations. In conclusion, this pilot study suggests that the presence of both obesity and persistent elevated serum ALT levels is associated with increased fecal SCFA concentrations and SCFA-producing bacteria, particularly <i>Roseburia</i>. However, a larger sample is required to define whether the associations of SCFA fecal levels with obesity and elevated ALT levels are independent.

Authors

Institutions

Publication Details

Journal
Journal of Nutrition and Metabolism
Published
2025-01-01
DOI
https://doi.org/10.1155/jnme/6652392
Citations
2
Primary Topic
Diet and metabolism studies
Type
article
Field-Weighted Citation Impact
2.33

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of Gut Microbiota‐Derived Short‐Chain Fatty Acids With Persistent Elevated Serum Transaminase Levels in Normal Weight and Obesity: A Pilot Study

Hugo Villamil‐Ramírez, Samuel Canizales‐Quinteros, Paola León‐Mimila, Blanca E. López-Contreras et al.
2 citations
Journal of Nutrition and Metabolism
Diet and metabolism studies
2.33
article

Association of Gut Microbiota‐Derived Short‐Chain Fatty Acids With Persistent Elevated Serum Transaminase Levels in Normal Weight and Obesity: A Pilot Study

Hugo Villamil‐Ramírez, Samuel Canizales‐Quinteros, Paola León‐Mimila, Blanca E. López-Contreras, Marisol Olivares-Arévalo, Maricela Rodríguez‐Cruz, Jorge Salmerón, David Alberto Díaz de Sandy-Galán, Jorge Maldonado‐Hernández, Rafael Velázquez‐Cruz, Daniel Cerqueda‐García, Teresa Villarreal‐Molina, Israel Domínguez-Calderón
article en
2 citations

Abstract

Although obesity is the most common risk factor for hepatic steatosis, this disease may occur in normal-weight individuals. While gut microbial metabolites such as short-chain fatty acids (SCFAs) have been associated with obesity and metabolic disease, the relationship among fecal SCFA concentrations, SCFA-producing bacteria, and hepatic steatosis with and without obesity is not fully understood. This pilot study aimed to compare fecal SCFA concentrations and SCFA-producing gut bacteria in four study groups: 7 individuals with normal-weight and normal alanine aminotransferase levels (Nw-N ALT), 7 individuals with normal-weight and elevated ALT levels (Nw-E ALT), 12 individuals with obesity and normal ALT levels and (Ob-N ALT), and 18 individuals with obesity and elevated ALT levels (Ob-E ALT). Fecal SCFA concentrations were quantified using gas chromatography, and gut microbiota was characterized by sequencing 16S rRNA. Median fecal SCFA concentrations (propionate, butyrate, and valerate) were highest in the Ob-E ALT group and lowest in the Nw-N ALT group (<i>p</i> < 0.05). These SCFA concentrations were also higher in obese than in normal-weight individuals regardless of ALT levels (<i>p</i> < 0.05) and in elevated ALT individuals regardless of obesity status, although the difference lost significance after correction for multiple testing. Notably, the abundance of <i>Roseburia</i> was higher in Ob-N ALT and Ob-E ALT than in the Nw-N ALT group and correlated positively with fecal SCFA concentrations. In conclusion, this pilot study suggests that the presence of both obesity and persistent elevated serum ALT levels is associated with increased fecal SCFA concentrations and SCFA-producing bacteria, particularly <i>Roseburia</i>. However, a larger sample is required to define whether the associations of SCFA fecal levels with obesity and elevated ALT levels are independent.

Journal of Nutrition and MetabolismVol. 2025(1)
Population Council (IN), Mexican Social Security Institute (MX), Tecnológico Nacional de México (MX), National Institute of Genomic Medicine (MX)
Universidad Nacional Autónoma de México
Openalex Percentile: Top 10%
Diet and metabolism studies
2.33
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.